Location: Home
  • search
  • go
  • WiCON News
    WiCON and major US investment firms seek M&A opportunities in the Chinese Pharma Industry 1/11/2006

    WiCON International Group has recently reached agreement with a number of major US investment firms to help them identify, screen and negotiate with potential M&A opportunities in the Chinese pharmaceutical industry.

    Ideal candidates should be profitable, have at least an annual sales of RMB 200 million, and need equity investment at and above US$20 million.

    Interested party please contact us at (010) 62354966 ext. 801 or e-mail: jshen@jicaipharma.com

        维康医药集团与数家美国中大型投资机构最近达成协议,协助他们在华寻找合适的中国制药企业进行战略投资。现寻求满足以下要求的中国药企:业绩良好,拥有较好的产品线,具有中长期发展潜力,目前年销售额在2亿以上,寻求战略投资数额在2000万美元以上。

        有意者可以与我公司联络(010)62354966转801或电邮:jshen@jicaipharma.com.


  • Site map | Contact Us | Links
  • © Wicon International Group Support by: www.heightow.com